Back to top


Dental Trade Alliance Chief Executive Officer

Greg Chavez joined DTA as the new Chief Executive Officer on April 1, 2020. Chavez brings more than 25 years of association management experience to the position and most recently served as executive vice president of operations and membership at The Vision Council. 

Mr. Buthusiem is a Managing Director in the BRG Health Analytics practice and a leader of its Corporate Compliance and Risk Management practice. He has over 30 years of experience advising clients on a variety of business, regulatory, operational, intellectual property, litigation, transactional and compliance matters, with particular emphasis in pharmaceutical and medical device product and technology licensing transactions, commercial and strategic transactions, business formation and planning, securities, mergers and acquisitions, compliance, and corporate governance. Since joining BRG in 2013, Mr. Buthusiem has provided expert testimony and support in a number of litigation matters involving, among other things, the interpretation of licensing and development contracts relating to pharmaceutical and medical device product development, deal structures, valuation and pricing, matters involving fiduciary responsibilities, securities disclosure, adequacy of internal controls and pharmaceutical pre-clinical and clinical development and commercialization.

Mr. Buthusiem has served as a government and court-appointed monitor for entities subject to post-settlement and post-acquisition mandates, including on behalf of the US Department of Justice (DOJ), the Securities and Exchange Commission (SEC) and the Office of Inspector General (OIG) in connection with various civil and criminal actions. Mr. Buthusiem has also served as a court-appointed monitor in connection with the disposition of assets in bankruptcy proceedings as well as an independent third party to oversee the implementation of post-closing obligations primarily involving M&A transactions. He has advised healthcare companies and their legal counsel in implementing Corporate Integrity Agreements (CIAs), as well as negotiating CIA terms with the Department of Justice, the OIG, the SEC, and other governmental agencies. Mr. Buthusiem has also developed and overseen all aspects of compliance programs, including auditing and monitoring; interactions and engagements with healthcare professionals; determining fair market value of goods and services provided by and offered to physicians; strategic marketing and sales initiatives; transparency reporting; and clinical, research and development, and post-market surveillance.

Chief Economist and Vice President of the
Health Policy Institute, American Dental Association

Marko Vujicic currently serves as Chief Economist and Vice President of the Health Policy Institute at the American Dental Association. Previously, he was Senior Economist with The World Bank in Washington D.C. where he focused on health systems reform in developing countries and directed the global health workforce policy program. He was also a Health Economist with the World Health Organization in Geneva, Switzerland. In all of these roles, Dr. Vujicic led large-scale strategic initiatives focused on bringing cutting edge data and research to specific health policy challenges.

Dr. Vujicic has published extensively in peer-reviewed journals such as Health Affairs, The New England Journal of Medicine, JAMA, Health Services Research, Health Economics, Social Science and Medicine, and Medical Care. He is also the lead author of the book, Working in Health, which examines health workforce challenges globally and has written several book chapters on health care policy issues. His team’s work has been cited by CNN, The New York Times, The Washington Post, The Wall Street Journal, Fox News, NOVA, and The Atlantic. He has been invited to provide testimony to federal and state legislative committees.

Dr. Vujicic holds several academic appointments. He is an adjunct senior fellow at the Leonard Davis Institute of Health Economics, University of Pennsylvania and affiliate faculty at the Center for Health and the Social Sciences, University of Chicago as well as the Center for Health Services and Policy Research at the University of British Columbia. He is an adjunct professor at the University of Toronto and a visiting assistant professor at Tufts University.

Dr. Vujicic obtained his Ph.D. in Economics from the University of British Columbia and a Bachelor’s degree in Business from McGill University in Montreal.

Wall Street Investment Visionary
Topic: Uncertainty Brings Opportunity

Peter Ricchiuti is the business professor you wish you had back in college. He teaches at Tulane University and has received numerous awards. In a competition, Peter’s teaching delivery skills placed him atop of entries from more than 400 universities representing 43 countries. He has been featured in/on The Wall Street Journal,  BARRON’s, The New York Times, Bloomberg, CNBC and The Nightly Business Report

Peter began his career at the investment firm of Kidder Peabody & Co in Boston and later managed more than $3 billion as the Chief Investment Officer for the State of Louisiana. He is the host of a popular weekly business show on NPR in New Orleans. Peter is a husband, father, author, media personality (and a darn good public speaker) who has attended games in all 30 current major league ballparks.

Executive Director of Raps

Paul Brooks is the Executive Director for the Regulatory Affairs Professional Society (RAPS) located in Rockville, Maryland.  Paul has more than 30 years’ experience in the medical device regulatory environment including his 25 plus years working with the British firm BSI (British Standards Institution) and was the Senior Vice President of BSI Americas Healthcare division.

Paul served on the Board of RAPS for five years before being appointed Executive Director. Paul has a long history of working with industry on quality assurance.  He was formally recognized as a third party for FDA’s Center for Devices and Radiological Health as well as Canada’s Canadian Medical Devices Conformity Assessment System. In addition, Paul spent years volunteering with various agencies and industry to help maintain high safety standards for new devices and technologies being evaluated for the US, Canadian and European marketplaces.


President of The Federal Group and DTA Legislative Representative

Patrick Cooney established The Federal Group, Inc. in 1999 with the objective of providing affordable, high quality government relations consulting services to companies, associations, municipalities and non-profit organizations.

Prior to establishing the firm, Mr. Cooney represented the interests of the national clinical laboratory scientists as Associate Director of Government Affairs for the American Society for Clinical Laboratory Science (ASCLS), and the physical therapists as the Senior Policy Advisor for the American Physical Therapy Association (APTA).   As the senior advocate for each of these organizations he was responsible for the federal legislative and political strategies of each profession on Capitol Hill.  ASCLS and APTA remain valued clients of The Federal Group today.

Mr. Cooney served as a congressional aide to Congressman Dick Swett (D-NH) who served the United States House of Representatives from 1991 – 1995.  He also served as the State Field Director on the 1990 reelection campaign of the late Senator Jim Exon (D-NE) who served as a Senator from 1979 – 1997.

Mr. Cooney has expansive knowledge of the legislative, regulatory, and political processes in Washington.  He frequently speaks on government relations matters, particularly in the area of health care policy. As a long time advocate for sound public health policy he formerly served as Chair of the Public Health Advisory Board for the City of Alexandria, Virginia.

Mr. Cooney is a graduate of the College of Business at Marquette University in Milwaukee, Wisconsin.  

Vice President, Unique Device Identification Services and Solutions, USDM Life Sciences

Jay was most recently Senior Advisor for Patient Safety in the Food and Drug Administration’s Center for Devices and Radiological Health. Jay developed the framework and authored key requirements for FDA’s Unique Device Identification system.

At USDM Life Sciences, Jay focuses exclusively on providing business process, technology and compliance solutions for the regulated life science industry.

Award-Winning Podcaster and Acclaimed Concert Pianist

Matthew Zachary is a community builder. After surviving end-stage brain cancer, he ignited a global movement of cancer renegades united in advocating for choice, equity, and a dignified path to a productive life.

As the Founder of Stupid Cancer, Inc., Matthew is one of today's most influential patient leaders. With a passion for storytelling, connecting people, and agitating the status quo, his legacy is to have galvanized the patient voice and challenged conventional wisdom about the art of survivorship.

Matthew is also an award-winning podcaster, recording artist, and acclaimed concert pianist.

Best-Selling Author and Leading Business and Data Expert
Topic: Artificial Intelligence in Practice

Bernard Marr is an internationally best-selling business author, keynote speaker and strategic advisor to companies and governments. He is one of the world's most highly respected voices anywhere when it comes to data in business and has been recognized by LinkedIn as one of the world's top 5 business influencers.

He is a regular contributor to the World Economic Forum, writes regular columns for Forbes and LinkedIn Pulse and his expert comments have been featured on TV and radio (e.g. BBC News, Sky News and BBC World) as well as in high-profile publications including The Times, The Financial Times, the CFO Magazine and the Wall Street Journal.

Bernard has written a number of seminal books and hundreds of high profile reports and articles, including the international best-sellers ‘Big Data in Practice: How 45 Successful Companies Used Big Data Analytics To Deliver Extraordinary Results’, 'Big Data: Using SMART Big Data, Analytics and Metrics To Make Better Decisions and Improve Performance', 'Key Business Analytics: The 60+ Business Analysis Tools Every Manager Needs to Know', 'The Intelligent Company' and 'Big Data for Small Business' in the For Dummies series.

Best-Selling Author and Management Consultant
Topic: Information to Action: Data Driven Decision Making

Michael Treacy is the President and founder of Treacy & Company. He brings over 30 years of experience helping companies achieve market leadership. Mr. Treacy’s ideas about customer value propositions and growth disciplines have been used by companies across the globe to reshape strategies, bolster competitive positions and dramatically improve top and bottom line performances.

Michael Treacy’s books have gained international attention.  In the 1990s he showed how to gain a competitive advantage through value leadership in The Discipline of Market Leaders a New York Times bestseller.  A decade later in Double Digit Growth, a Business Week bestseller, he proved how rapid, steady and profitable growth can be dialed up on purpose.

A former professor of management at the Sloan School of Management at Massachusetts Institute of Technology, Michael Treacy has published numerous articles over the past two decades in magazines and journals and is a frequent contributor to the Harvard Business Review.  He is also currently engaged in a major research study to understand the performance discipline that allows certain companies to routinely achieve high performance – in growth, cost control, safety, or other important goals – while other firms struggle with uncertain results.


Subscribe to RSS - Presenter